NCT03477266View on ClinicalTrials.gov

Mouth Dissolving Mosapride Tables Enhance Post Cesarean Gut Recovery

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

June 1, 2018

Study Completion Date

August 1, 2018

Conditions
Prevention of Postoperative Ileus
Interventions
DRUG

Mosapride

Intake mouthly dissolving mosapride tablets in immediate post cesarean section

DRUG

Placebo Oral Tablet

Dummy identical tablets to mouthly dissolving mosapride tablets

Trial Locations (1)

Unknown

Ashraf nassif Elmantwe, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT03477266 - Mouth Dissolving Mosapride Tables Enhance Post Cesarean Gut Recovery | Biotech Hunter | Biotech Hunter